Cleared Special

K182960 - ReliefBand

K182960 is the FDA 510(k) clearance for ReliefBand by Reliefband Technologies, LLC. It is a Class 2 Neurology device (product code GZJ) cleared through the Special 510(k) pathway after a 239-day FDA review.

K182960 · Reliefband Technologies, LLC · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2019
Decision
239d
Days
Class 2
Risk

K182960 is an FDA 510(k) clearance for the ReliefBand. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Reliefband Technologies, LLC (Horsham, US). The FDA issued a Cleared decision on June 21, 2019 after a review of 239 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Reliefband Technologies, LLC devices

Submission Details

510(k) Number K182960 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 25, 2018
Decision Date June 21, 2019
Days to Decision 239 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
91d slower than avg
Panel avg: 148d · This submission: 239d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 116
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K182960.
OGYILI TENS/NMES Stimulator
K201431 · Gongguan Tutamen Metalwork Co., Ltd. · Nov 2020
StimaWELL 120MTRS
K181645 · Pierenkemper GmbH · Aug 2020
ReliefBand
K191547 · Reliefband Technologies, LLC · Aug 2019
ClearUP Sinus Pain Relief
K182025 · Tivic Health Systems, Inc. · Jan 2019
BioWaveGO
K180943 · Biowave Corporation · Aug 2018
TENS device-EmeTerm, CinvStop
K172478 · Wat Medical Technology (Ningbo) Co., Ltd. · Apr 2018